The store will not work correctly when cookies are disabled.
3-(2,3-dichlorostyryl)-2-methylquinazolin-4(3H)-one
ID: ALA5280821
Max Phase: Preclinical
Molecular Formula: C17H12Cl2N2O
Molecular Weight: 331.20
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: Cc1nc2ccccc2c(=O)n1/C=C/c1cccc(Cl)c1Cl
Standard InChI: InChI=1S/C17H12Cl2N2O/c1-11-20-15-8-3-2-6-13(15)17(22)21(11)10-9-12-5-4-7-14(18)16(12)19/h2-10H,1H3/b10-9+
Standard InChI Key: YRVKHNPJRUNYRW-MDZDMXLPSA-N
Molfile:
RDKit 2D
22 24 0 0 0 0 0 0 0 0999 V2000
0.3567 -1.8511 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.3577 -1.4387 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.3577 -0.6178 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.3549 -0.2053 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0693 -0.6178 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7840 -0.2053 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5013 -0.6196 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2129 -0.2032 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2129 0.6176 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4967 1.0302 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7840 0.6196 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0695 1.0321 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
2.4967 1.8552 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
-1.0743 -0.2054 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0743 0.6195 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.7868 -0.6162 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.7868 -1.4412 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0692 -1.8552 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.4967 -1.8529 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.2129 -1.4449 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.2129 -0.6166 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.4985 -0.2044 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
2 3 1 0
3 4 1 0
4 5 2 0
5 6 1 0
6 7 1 0
7 8 2 0
8 9 1 0
9 10 2 0
10 11 1 0
11 6 2 0
11 12 1 0
10 13 1 0
3 14 1 0
14 15 2 0
16 14 1 0
17 16 2 0
17 18 1 0
18 2 2 0
19 17 1 0
20 19 2 0
21 20 1 0
22 21 2 0
16 22 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 331.20 | Molecular Weight (Monoisotopic): 330.0327 | AlogP: 4.64 | #Rotatable Bonds: 2 |
Polar Surface Area: 34.89 | Molecular Species: NEUTRAL | HBA: 3 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 3 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 4.87 | CX LogP: 4.31 | CX LogD: 4.31 |
Aromatic Rings: 3 | Heavy Atoms: 22 | QED Weighted: 0.69 | Np Likeness Score: -0.96 |
References
1. Alagarsamy V, Chitra K, Saravanan G, Solomon VR, Sulthana MT, Narendhar B.. (2018) An overview of quinazolines: Pharmacological significance and recent developments., 151 [PMID:29656203] [10.1016/j.ejmech.2018.03.076] |